Evidence map›Paper›PMID 31380455›Full record

ArticleAsia Oceania journal of nuclear medicine & biology2019

Sentinel ode apping in on-small ell ung ancer sing an ntraoperative adiotracer echnique.

Susan Shafiei, Reza Bagheri, Ramin Sadeghi, Vahid Reza Dabbagh Kakhki, Amir Hossein Jafarian, Reza Afghani, Davood Attaran, Reza Basiri, Shahrzad M Lari

Abstract read
In one paragraph

Article in Asia Oceania journal of nuclear medicine & biology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Susan ShafieiNuclear Medicine Research Center, Mashhad University of Medical Sciences, Mashhad, Iran.
Reza BagheriLung Diseases Research Center, Mashhad University of Medical Sciences, Mashhad, Iran.
Ramin SadeghiNuclear Medicine Research Center, Mashhad University of Medical Sciences, Mashhad, Iran.
Vahid Reza Dabbagh KakhkiNuclear Medicine Research Center, Mashhad University of Medical Sciences, Mashhad, Iran.
Amir Hossein JafarianCancer Molecular Pathology Research Center, Ghaem Hospital, School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.
Reza AfghaniThoracic Surgeon, Department of General Surgery, Azar Hospital, Golestan University of Medical Science, Gorgan, Iran.
Davood AttaranLung Disease Research Center, Faculty of Medicine, Mashhad University of Medicine Sciences, Mashhad, Iran.
Reza BasiriLung Disease Research Center, Faculty of Medicine, Mashhad University of Medicine Sciences, Mashhad, Iran.
Shahrzad M LariLung Disease Research Center, Faculty of Medicine, Mashhad University of Medicine Sciences, Mashhad, Iran.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesLymph node metastases are the most significant prognostic factor in localized non-small cell lung cancer (NSCLC). Identification of the first nodal drainage site (sentinel node) may improve detection of metastatic nodes. Extended surgeries, such as lobectomy or pneumonectomy with lymph node dissection, are among the therapeutic options of higher acceptability. Sentinel node biopsy can be an alternative approach to less invasive surgeries. The current study was conducted to evaluate the accuracy of sentinel node mapping in patients with NSCLC using an intraoperative radiotracer techniques.

methodsThis prospective study was conducted on 21 patients with biopsy-proven NSCLC who were candidates for sentinel node mapping during 2012-2014. All patients underwent thoracoabdominal computed tomography, based on which they had no lymph node involvement. Immediately after thoracotomy and before mobilizing the tumor, peritumoral injection of 2mCi/0.4 mL Tc-99m- phytate was performed in 4 corners of tumor. After mobilization of the tumoral tissues, the sentinel nodes were searched for in the hillar and mediastinal areas using hand-held gamma probe . Any lymph node with in vivo count twice the background was considered as sentinel node and removed and sent for frozen section evaluation. All dissected nodes were evaluated by step sectioning and hematoxylin and eosin staining (H&E).The recorded data included age, gender, kind of pathology, site of lesion, number of dissected sentinel nodes, number of sentinel nodes, and site of sentinel nodes. Data analysis was performed in SPSS software (version 22).

resultsThe mean age of the patients was 58.52±11.46 years with a male to female ratio of 15/6. The left lower lobe was the most commonly affected site (30.09%). Squamous cell carcinoma and adenocarcinoma were detected in 11 and 10 subjects, respectively. A total of 120 lymph nodes were harvested with the mean number of 5.71±2.9 lymph nodes per patient. At least one sentinel node was identified in each patient, resulting in a detection rate of 95.2%. The mean number of sentinel nodes per patient was 3.61±2. Frozen section results showed 100% concordance with the results of hematoxylin and eosin staining.

conclusionBased on the findings, sentinel node mapping can be considered feasible and accurate for lymph node staging and NSCLC treatment.

Indexed as

Non-small cell lung cancerRadiotracerSentinel node

Identifiers

PMID31380455
PMCPMC6661315

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.